Parainfluenza remains a significant public health concern due to its ability to cause severe respiratory illness in vulnerable populations and its potential to lead to widespread outbreaks. Understanding its transmission, symptoms, and preventive measures can help mitigate its impact on public health.

What is parainfluenza?

Parainfluenza also known as human parainfluenza viruses (HPIV) are a group of viruses known for causing upper and lower respiratory illnesses. Parainfluenza viruses are classified into four categories: HPIV-1, HPIV-2, HPIV-3, and HPIV-4.^1,11 Small children regularly contract croup from HPIV-1 and HPIV-2, bronchiolitis and pneumonia are connected to HPIV-3. Respiratory infections can also be brought on by HPIV-4, though more rarely.^2,16

How do people get parainfluenza virus?

Parainfluenza viruses can be contracted by anyone but they are more common in children, the elderly and immunocompromised individuals.³ HPIVs are spread through respiratory droplets, direct contact, and contaminated surfaces.⁸ The virus can spread easily in crowded places, such as daycare centres, schools, and healthcare facilities, leading to outbreaks.⁶

Symptoms 

The symptoms of parainfluenza vary depending on the type of HPIV and the individual's age and health status.⁴ Symptoms range from mild to severe and these include:

• Coughing
• Fever
• Sore throat
• Shortness of breath
• Runny or stuffy nose

In children, parainfluenza can cause more severe symptoms such as:

• Barking cough and hoarseness (croup)
• Stridor (a high-pitched wheezing sound)
• Rapid or laboured breathing
• Severe respiratory distress in severe cases

Public health impact

It is possible to have serious complications arising from HPIV infections especially in populations that are already vulnerable. Youngsters under five are particularly vulnerable to croup, while newborns and individuals with underlying medical issues may get pneumonia or bronchiolitis.⁷ The impact of HPIVs is further influenced by socioeconomic and geographic differences, with low-income and rural populations frequently encountering more difficulties in treating infections and obtaining healthcare.¹² They are the main reason kids are admitted to hospitals for respiratory ailments. During HPIV outbreaks, the demand for medical care puts a burden on healthcare systems, driving up costs and necessitating the deployment of substantial resources for infection control and management.

Preventing and managing HPIV infections is greatly aided by public health initiatives. Wearing a mask and practising good hygiene can help stop the infection from spreading.¹³ Early epidemic detection and surveillance allow for timely public health responses. Policies pertaining to isolation and quarantine are crucial in order to stop the spread of an outbreak.¹⁵ Although research is continuing, there are no approved vaccinations for HPIVs at this time. The differences in the infections display obstacles in the advancement of effective vaccinations. 

Diagnosis and testing

Lab testing and clinical appraisal are utilised in the determination of parainfluenza. Typically, medical professionals will take into account the patient's symptoms, medical history, and results of the physical examination. The following laboratory tests are used to confirm HPIV infection:

• Reverse Transcription Polymerase Chain Reaction (RT-PCR): The most sensitive technique is reverse transcription polymerase chain reaction, or RT-PCR, which finds the genetic material of the virus^9,10
• Viral culture: This approach is less popular because it takes longer to see results and entails cultivating the virus in a lab environment
• Assays using immunofluorescence: These methods identify viral antigens in respiratory samples.
• Serology: This is the study of finding antibodies to a virus in blood; it is less helpful for acute diagnosis but useful for epidemiological studies¹⁷

Management and treatment

There isn't a specific antiviral medication available for parainfluenza right now.¹⁷ The goals of management are to help the patient during their illness and to relieve their symptoms.⁵ One of the treatment options is to make sure that you are getting enough fluids to stay hydrated. Fever and pain is treated with analgesics and antipyretics, such as acetaminophen or ibuprofen. Breathing can be made easier by using a cool-mist humidifier. Hospitalisation could be necessary in extreme situations, especially if there are complications like pneumonia or croup. Hospital treatments for severe croup may involve nebulized epinephrine to minimise airway edema and oxygen therapy to maintain appropriate blood oxygen levels. In addition, corticosteroids are often used to reduce airway inflammation.^{13, 17}

Prevention

Preventing the spread of parainfluenza involves several strategies:

• Hand cleanliness: Regularly handwashing with cleanser and water or utilising hand sanitizer
• Respiratory behaviour: Covering the mouth and nose with a tissue or elbow when coughing or sneezing
• Avoiding close contact: Staying away from infected individuals, especially for those at higher risk, such as young children and the elderly
• Surface disinfection: Regularly cleaning and disinfecting frequently touched surfaces

Importance of global collaboration 

Global collaboration is essential for monitoring and controlling the spread of HPIVs. International efforts in surveillance, research, and response strategies contribute to a comprehensive understanding of these viruses and enhance public health preparedness. Collaborative initiatives can accelerate the development of vaccines and treatments, improving outcomes for affected populations worldwide.¹⁴

FAQ’s

Can an adult contract parainfluenza?

Indeed, adults can contract parainfluenza, but they often experience milder symptoms than children. More serious illnesses, however, are more likely to strike older persons and people with compromised immune systems.

Is influenza(flu) and parainfluenza the same thing?

No, influenza and parainfluenza are not caused by the same virus. Human parainfluenza viruses (HPIVs) cause parainfluenza, whilst the flu virus causes flu. Though the disorders may present with similar symptoms, they are different.

How long is a person contagious with parainfluenza?

Parainfluenza patients can spread the illness for up to a week after symptoms begin, and they are usually contagious for many days prior to symptoms showing.

Can parainfluenza have long-term effects?

Most cases of parainfluenza are entirely recovered without any lasting symptoms. Severe cases, however, especially in small children and the elderly, might result in complications such as pneumonia, necessitating a longer period of recuperation.

Can you get parainfluenza more than once?

It is true that you can contract parainfluenza more than once. HPIVs come in various forms, and immunity to one does not provide protection against others. Furthermore, immunity may gradually decline, leaving room for reinfection.

Summary

Parainfluenza viruses (HPIVs) are significant contributors to respiratory illnesses, particularly in children, the elderly, and immunocompromised individuals. The four types of HPIVs (HPIV-1, HPIV-2, HPIV-3, and HPIV-4) cause symptoms ranging from mild cold-like issues to severe respiratory conditions like croup and pneumonia. These viruses spread through respiratory droplets and surface contact. Diagnosis involves clinical evaluation and laboratory tests such as RT-PCR. Treatment focuses on symptom management, as no specific antiviral therapy exists. Preventive measures include good hygiene, respiratory etiquette, and avoiding close contact with infected individuals. While most people recover without long-term effects, severe cases can lead to complications, highlighting the need for effective public health strategies to manage and prevent parainfluenza infections.